164 related articles for article (PubMed ID: 19646360)
1. Early diagnosis of pediatric Takayasu arteritis (TA) not fullfiling the ACR criteria.
Bracaglia C; Buonuomo PS; Campana A; Insalaco A; Nicolai R; Cortis E
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S140. PubMed ID: 19646360
[No Abstract] [Full Text] [Related]
2. Combined immunosuppressive therapy including a TNF-alpha blocker induces remission in a difficult to treat patient with Takayasu arteriitis and coronary involvement.
Mahlmann A; Pfluecke C; Ouda A; Simonis G; Weiss N; Kappert U
Vasa; 2012 Nov; 41(6):451-7. PubMed ID: 23129041
[TBL] [Abstract][Full Text] [Related]
3. Takayasu Arteritis in the pediatric population: a contemporary United States-based single center cohort.
Szugye HS; Zeft AS; Spalding SJ
Pediatr Rheumatol Online J; 2014; 12():21. PubMed ID: 24955077
[TBL] [Abstract][Full Text] [Related]
4. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
5. Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate.
Tanaka F; Kawakami A; Iwanaga N; Tamai M; Izumi Y; Aratake K; Arima K; Kamachi M; Nakamura H; Huang M; Ida H; Origuchi T; Eguchi K
Intern Med; 2006; 45(5):313-6. PubMed ID: 16596001
[TBL] [Abstract][Full Text] [Related]
6. Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.
Calderón R; Estrada S; Ramírez de la Piscina P; Salvador M; Zabaleta S; Enciso C; Delgado E; García-Campos F
Rev Esp Enferm Dig; 2010 Feb; 102(2):145-6. PubMed ID: 20361852
[No Abstract] [Full Text] [Related]
7. Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques.
Freitas DS; Camargo CZ; Mariz HA; Arraes AE; de Souza AW
Rheumatol Int; 2012 Mar; 32(3):703-9. PubMed ID: 21152919
[TBL] [Abstract][Full Text] [Related]
8. Juvenile-onset Takayasu arteritis: peculiar vascular involvement and more refractory disease.
Jales-Neto LH; Levy-Neto M; Bonfa E; de Carvalho JF; Pereira RM
Scand J Rheumatol; 2010 Nov; 39(6):506-10. PubMed ID: 20560810
[TBL] [Abstract][Full Text] [Related]
9. Successful tocilizumab treatment in a child with refractory Takayasu arteritis.
Bravo Mancheño B; Perin F; Guez Vázquez Del Rey Mdel M; García Sánchez A; Alcázar Romero PP
Pediatrics; 2012 Dec; 130(6):e1720-4. PubMed ID: 23147976
[TBL] [Abstract][Full Text] [Related]
10. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate.
Ozen S; Duzova A; Bakkaloglu A; Bilginer Y; Cil BE; Demircin M; Davin JC; Bakkaloğlu M
J Pediatr; 2007 Jan; 150(1):72-6. PubMed ID: 17188618
[TBL] [Abstract][Full Text] [Related]
11. [Takayasu's arteritis--case report and review of the literature].
Schurch MA; Gerster JC
Rev Med Suisse Romande; 2000 Oct; 120(10):777-80. PubMed ID: 11109906
[TBL] [Abstract][Full Text] [Related]
12. Blind runner.
Pelegrín L; Mesquida M; Rey A; Sánchez-Dalmau B; Frohman L
Surv Ophthalmol; 2012 Sep; 57(5):486-94. PubMed ID: 22018675
[TBL] [Abstract][Full Text] [Related]
13. Patient with Takayasu arteritis presented as cardiogenic shock.
Tacoy G; Akyel A; Tavil Y; Cengel A
Future Cardiol; 2010 Nov; 6(6):889-93. PubMed ID: 21142644
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.
Schmidt J; Kermani TA; Bacani AK; Crowson CS; Matteson EL; Warrington KJ
Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1079-83. PubMed ID: 22328491
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.
Hoffman GS; Merkel PA; Brasington RD; Lenschow DJ; Liang P
Arthritis Rheum; 2004 Jul; 50(7):2296-304. PubMed ID: 15248230
[TBL] [Abstract][Full Text] [Related]
16. Reduced aortic elastic properties in a child with Takayasu arteritis: case report and literature review.
Baumgartner D; Sailer-Höck M; Baumgartner C; Trieb T; Maurer H; Schirmer M; Zimmerhackl LB; Stein JI
Eur J Pediatr; 2005 Nov; 164(11):685-90. PubMed ID: 16044277
[TBL] [Abstract][Full Text] [Related]
17. [Takayasu arteritis: a French single centre experience].
Arnaud L; Haroche J; Piette JC; Amoura Z
Rev Med Interne; 2010 Mar; 31(3):208-15. PubMed ID: 19299046
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification.
Park MC; Lee SW; Park YB; Chung NS; Lee SK
Scand J Rheumatol; 2005; 34(4):284-92. PubMed ID: 16195161
[TBL] [Abstract][Full Text] [Related]
19. Rapid control of disease activity by tocilizumab in 10 'difficult-to-treat' cases of Takayasu arteritis.
Goel R; Danda D; Kumar S; Joseph G
Int J Rheum Dis; 2013 Dec; 16(6):754-61. PubMed ID: 24382284
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of leflunomide in glucocorticoid- and methotrexate-resistant Takayasu's arteritis.
Haberhauer G; Kittl EM; Dunky A; Feyertag J; Bauer K
Clin Exp Rheumatol; 2001; 19(4):477-8. PubMed ID: 11491512
[No Abstract] [Full Text] [Related]
[Next] [New Search]
